Novartis Annual Results

Annual Results 2020 - Jan 26, 2021

Media release

English (PDF 0.2 MB)

Deutsch (PDF 0.2 MB)

Français (PDF 0.2 MB)

Condensed financial report (PDF 0.9 MB)

Webcasts and presentations

Press conference

Watch the virtual press conference

Download the press conference presentation (PDF 1.5 MB)

Investors

Watch the investor webcast

Read the presentation transcript

Download the podcast (MP3 45 MB)

Download the investor presentation (PDF 3.6 MB)

Access our interactive slide deck (PDF 12 MB)

 

---

Annual Report and US Securities & Exchange Commission Form 20-F

These reports, filed with the SIX Swiss Exchange in Switzerland and the US Securities and Exchange Commission (SEC) in the US, provide a comprehensive overview of Novartis, including our company structure, corporate governance and compensation practices. They also disclose our operating and financial results, accompanied by audited annual financial statements.

Download the Novartis Annual Report 2020 (SIX filing) (PDF 3.6 MB)

Download the Novartis Form 20-F 2020 (SEC filing) (PDF 3.4 MB)

To request a hard copy of the Annual Report and/or SEC Form 20-F, fill out the order form.

Annual Results 2019 - Jan 29, 2020

 

Key figures2	Continuing operations1
	FY 2019 (USD m)	FY 2018 (USD m)	% change (USD/cc)
Net sales	47,445	44,751	6 (cc: 9)
Operating income	9,086	8,403	8 (cc: 14)
Net income	7,147	12,800	-44 (cc: -41)
EPS (USD)	3.12	5.52	-43 (cc: -40)
Free cash flow	12,937	11,256	15
Core
Operating income	14,112	12,557	12 (cc: 17)
Net income	12,104	10,920	11 (cc: 15)
EPS (USD)	5.28	4.71	12 (cc: 17)

 

1. Refers to continuing operations as defined on page 45 of the Condensed Financial Report, excludes Alcon, includes the businesses of Innovative Medicines and Sandoz (including the US generic oral solids and dermatology portfolio), as well as the continuing corporate functions.
2. Constant currencies (cc), core results and free cash flow are non-IFRS measures. An explanation of non-IFRS measures can be found on page 58 of the Condensed Financial Report. Unless otherwise noted, all growth rates in this Release refer to same period in prior year.

 

Media release

English (PDF 0.1 MB)

Deutsch (PDF 0.1 MB)

Français (PDF 0.1 MB)

 

Condensed financial report (PDF 0.6 MB)

---

Read the presentation transcript

Download the podcast (MP3 43 MB)

Download the presentation (PDF 3.6 MB)

Annual Results 2017 - Jan 24, 2018

 

Key figures1	FY 2017 (USD m)	FY 2016 (USD m)	% change (USD/cc)
Net sales	49,109	48,518	1 (cc: 2)
Operating income	8,629	8,268	4 (cc: 7)
Net income	7,703	6,698	15 (cc: 12)
EPS (USD)	3.28	2.82	16 (cc: 14)
Free cash flow	10,428	9,455	10
Core
Operating income	12,850	12,987	-1 (cc: 0)
Net income	11,391	11,314	1 (cc: 2)
EPS (USD)	4.86	4.75	2 (cc: 3)

 

1. Constant currencies (cc), core results and free cash flow are non-IFRS measures. An explanation of non-IFRS measures can be found on page 42 of the Condensed Financial Report. Unless otherwise noted, all growth rates in this Release refer to same period in prior year.

 

Media release

English (PDF 0.4 MB)

Deutsch (PDF 0.3 MB)

Français (PDF 0.5 MB)

 

Condensed financial report (PDF 0.5 MB)